-
1دورية أكاديمية
المؤلفون: Remmelink, M.J., Oddens, J.R., Nieuwenhuijzen, J.A., Voortman, J., de Reijke, T.M., Beerlage, H.P., van der Hulle, T., Daniëls, L.A., Bins, A.D.
المصدر: European Urology Open Science ; volume 57, page S12-S13 ; ISSN 2666-1683
مصطلحات موضوعية: Urology
الإتاحة: https://doi.org/10.1016/s2666-1683Test(23)01305-8
https://api.elsevier.com/content/article/PII:S2666168323013058?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666168323013058?httpAccept=text/plainTest -
2دورية أكاديمية
المؤلفون: Post, H C, Schutte, T, Voortman, J, Bartelink, I H, van Laarhoven, H W M, Crul, M
المصدر: Post , H C , Schutte , T , Voortman , J , Bartelink , I H , van Laarhoven , H W M & Crul , M 2024 , ' The narrow road to expanded access ' , Journal of Cancer Policy , vol. 41 , 100490 , pp. 100490 . https://doi.org/10.1016Test/j.jcpo.2024.100490
الإتاحة: https://doi.org/10.1016Test/j.jcpo.2024.100490
https://research.vumc.nl/en/publications/985aa3c1-114e-4eb3-ba04-08ea5134a62bTest
http://www.scopus.com/inward/record.url?scp=85195390688&partnerID=8YFLogxKTest -
3دورية أكاديمية
المؤلفون: Verhoeff, Sarah, van de Donk, Pim P., Aarntzen, Erik H., Oosting, Sjoukje F., Brouwers, Adrienne H., Miedema, IHC, Voortman, J, Menke, C. W., Boellaard, R, Vriens, Dennis, Slingerland, Marije, Hermsen, Rick, van Engen-van Grunsven, Ilse A C H, Heskamp, Sandra, van Herpen, Carla M L
المصدر: Verhoeff , S , van de Donk , P P , Aarntzen , E H , Oosting , S F , Brouwers , A H , Miedema , IHC , Voortman , J , Menke , C W , Boellaard , R , Vriens , D , Slingerland , M , Hermsen , R , van Engen-van Grunsven , I A C H , Heskamp , S & van Herpen , C M L 2022 , ' 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer ' , Journal of Nuclear Medicine , ....
الإتاحة: https://doi.org/10.2967/jnumed.121.263470Test
https://research.vumc.nl/en/publications/7c438a01-07ca-48ad-b654-f741ca44e895Test
http://www.scopus.com/inward/record.url?scp=85136062198&partnerID=8YFLogxKTest -
4مؤتمر
المؤلفون: Voortman, J
المصدر: Voortman , J 2020 , ' Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study. ' , ASCO 2020 Virtual Annual Meeting , 01/06/2020 . https://doi.org/10.1200/JCO.2020.38.15_suppl.5035Test
الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.5035Test
https://research.vumc.nl/en/publications/d5a561d2-da51-4065-ba25-0af28a6d2458Test -
5مؤتمر
المؤلفون: Voortman, J
المصدر: Voortman , J 2020 , ' 89Zr-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck. ' , ASCO 2020 Virtual Annual Meeting , 01/06/2020 . https://doi.org/10.1200/JCO.2020.38.15_suppl.3573Test
الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.3573Test
https://research.vumc.nl/en/publications/ac6341d0-14fa-44a7-bdff-e1c07e7b763dTest -
6مؤتمر
المؤلفون: Voortman, J
المصدر: Voortman , J 2020 , ' Early response marker during pembrolizumab treatment in metastatic urothelial cancer: Temporal shift in peripheral CD4 T cells expressing chemokine receptors. ' , ASCO 2020 Virtual Annual Meeting , 01/06/2020 . https://doi.org/10.1200/JCO.2020.38.15_suppl.5033Test
الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.5033Test
https://research.vumc.nl/en/publications/9916d090-6c62-4625-b168-e61e0ccf29b4Test -
7دورية أكاديمية
المؤلفون: van Nieuwenhuizen, A. J., Buffart, L. M., Langendijk, J. A., Vergeer, M. R., Voortman, J., Leemans, C. R., Verdonck-de Leeuw, I. M.
المصدر: van Nieuwenhuizen , A J , Buffart , L M , Langendijk , J A , Vergeer , M R , Voortman , J , Leemans , C R & Verdonck-de Leeuw , I M 2021 , ' Health-related quality of life and overall survival : a prospective study in patients with head and neck cancer treated with radiotherapy ' , Quality of Life Research , vol. 30 , no. 4 , pp. 1145-1153 . https://doi.org/10.1007/s11136-020-02716-xTest , https://doi.org/10.1007/s11136-020-02716-xTest
الإتاحة: https://doi.org/10.1007/s11136-020-02716-xTest
https://research.vumc.nl/en/publications/9ebd038a-e49a-4dac-9a9d-6e2731031137Test
http://www.scopus.com/inward/record.url?scp=85097288242&partnerID=8YFLogxKTest -
8دورية أكاديمية
المؤلفون: Hinsenveld, F. J., Noordman, B. J., Boormans, J. L., Voortman, J., van Leenders, G. J. L. H., van der Pas, S. L., van Beek, S. C., Oprea-Lager, D. E., Vis, A. N.
المصدر: Hinsenveld , F J , Noordman , B J , Boormans , J L , Voortman , J , van Leenders , G J L H , van der Pas , S L , van Beek , S C , Oprea-Lager , D E & Vis , A N 2021 , ' Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer : the PRE-PREVENCYS trial ' , BMC Cancer , vol. 21 , no. 1 , 1161 , pp. 1161 . https://doi.org/10.1186/s12885-021-08840-2Test , https://doi.org/10.1186/s12885-021-08840-2Test
الإتاحة: https://doi.org/10.1186/s12885-021-08840-2Test
https://research.vumc.nl/en/publications/6635ea39-8c5d-4582-b6a0-290adfc3283dTest
http://www.scopus.com/inward/record.url?scp=85118276617&partnerID=8YFLogxKTest -
9دورية أكاديمية
المؤلفون: Cysouw, M. C.F., Jansen, B. H.E., Yaqub, M., Voortman, J., Vis, A. N., van Moorselaar, R. J.A., Hoekstra, O. S., Boellaard, R., Oprea-Lager, D. E.
المصدر: Cysouw , M C F , Jansen , B H E , Yaqub , M , Voortman , J , Vis , A N , van Moorselaar , R J A , Hoekstra , O S , Boellaard , R & Oprea-Lager , D E 2020 , ' Correction to : Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake (Molecular Imaging and Biology, (2020), 22, 1, (15-17), 10.1007/s11307-019-01438-y) ' , Molecular Imaging and Biology , vol. 22 , no. 1 . https://doi.org/10.1007/s11307-019-01448-wTest
الإتاحة: https://doi.org/10.1007/s11307-019-01448-w10.1007/s11307-019-01438-yTest
https://research.vumc.nl/en/publications/d5fae98a-c1ba-44cc-a5f8-4dc0800603ceTest
http://www.scopus.com/inward/record.url?scp=85077526891&partnerID=8YFLogxKTest -
10دورية أكاديمية
المؤلفون: Voortman, J
المصدر: Voortman , J 2020 , ' Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors. ' , Journal of Clinical Oncology , vol. 38 , no. 15 , 3003 . https://doi.org/10.1200/JCO.2020.38.15_suppl.3003Test
الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.3003Test
https://research.vumc.nl/en/publications/b9cf00e1-8c9e-4c6b-b8aa-aab2b8c2eac8Test